4-Hydroxyandrostenedione in the prophylaxis of N-methyl-N-nitrosourea induced mammary tumourigenesis.

We have examined the role of the aromatase inhibitor 4-hydroxyandrostenedione (4-OHA) in the prevention of mammary tumourigenesis in experiments involving 170 rats. We first demonstrated a prophylactic effect of 4-OHA (50 mg/week) in reducing tumour incidence over a 30 week period compared to contro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Coombes, R. C., Wilkinson, J. R., Bliss, J. M., Shah, P., Easton, D. F., Dowsett, M.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 1991
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977518/
https://ncbi.nlm.nih.gov/pubmed/1892751
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars